Business
iTonic Holdings Ltd Granted An Extension of Additional 180-Day by Nasdaq to Regain Compliance with Minimum Bid Price Rule
BEIJING, China, April 23, 2026 (GLOBE NEWSWIRE) -- iTonic Holdings Ltd (the “Company” or “ITOC”), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today announced that on April 21, 2026, it received notification from The Nasdaq Stock Market LLC (“Nasdaq”) that Nasdaq approved the Company’s request for an extension of additional 180-calendar day, or until October 19, 2026 (the “Extension”) to regain compliance wit
About this update from Itonic Holdings Ltd
[{"type":"image","alt":"iTonic Holdings Ltd","displaySize":"","headline":null,"caption":"iTonic Holdings Ltd","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":134,"url":"https://media.zenfs.com/en/globenewswire.com/952011f91d3705f47c2246bb9174b7f9"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ApYgj46TOp.MXqleK1K07A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE4OA--/https://media.zenfs.com/en/globenewswire.com/952011f91d3705f47c2246bb9174b7f9","width":300,"height":134}},"lazy":false},{"type":"text","content":"BEIJING, China, April 23, 2026 (GLOBE NEWSWIRE) -- iTonic Holdings Ltd (the “Company” or “ITOC”), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today announced that on April 21, 2026, it received notification from The Nasdaq Stock Market LLC (“Nasdaq”) that Nasdaq approved the Company’s request for an extension of additional 180-calendar day, or until October 19, 2026 (the “Extension”) to regain compliance with the minimum closing bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”).The Extension follows the expiration the initial 180-calendar day compliance period on April 20, 2026.","length":721,"tagName":"p"},{"type":"text","content":"If the Company does not regain compliance with the Minimum Bid Price Rule by October 19, 2026, Nasdaq has informed the Company that it will provide written notification that the Company’s Class A ordinary shares will be delisted. At that time, the Company may request a review of the delisting determination by a Nasdaq Hearings Panel.","length":335,"tagName":"p"},{"type":"text","content":"About iTonic Holdings Ltd","length":25,"tagName":"p"},{"type":"text","content":"Founded in 1998, iTonic Holdings Ltd, through its wholly owned operating subsidiary, Beijing Feitian Zhaoye Technology Co., Ltd., focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its lead product, Beijing Feitian’s Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors. iTonic Holdings Ltd is committed to leveraging its products and services to establish a potential new standard of care across multiple malignant tumor applications. For m...